• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; STYLET, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; STYLET, CATHETER Back to Search Results
Model Number LLD EZ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Iatrogenic Source (2498); Device Embedded In Tissue or Plaque (3165)
Event Date 11/27/2020
Event Type  Injury  
Event Description
A lead extraction procedure commenced to remove three right ventricular (rv) leads due to cied system/pocket infection.The models of the leads to be removed were as follows: medtronic sprint quattro secure, medtronic sprint quattro and st.Jude medical sj riata.It was reported that the sprint quattro was removed with simple traction.After that, spectranetics lead locking devices (lld''s) were inserted in the two remaining rv leads to provide traction to aid in extraction.A cook medical dilator was first used and then a spectranetics 13f tightrail rotating dilator sheath.It was reported that the riata lead could not be removed due to externalization of the lead''s inner conductors.The physician was reportedly able to free the single coil sprint quattro secure, but could not remove the lead via the subclavian vein.The physician then used a needle's eye snare to successfully extract this lead from a femoral approach.One minute after the extraction, a sudden drop in blood pressure was noticed with a stable blood pressure.Rescue efforts began immediately; transesophageal echocardiography (tee) showed a massive emboli (it was determined that spectranetics devices did not cause nor contribute to the emboli).The patient''s condition deteriorated and resuscitation started.After one hour, the patient was stabilized and extracorporeal membrane oxygenation (ecmo) was used.The riata lead and the lld present within the riata lead were cut and capped and remained in the patient''s body.The physician did not attempt to unlock the lld prior to cutting and capping it within the riata lead.Despite efforts, the patient died a day after the procedure on (b)(6) 2020.This report is being submitted for the lld which was present within the riata lead and was cut, capped, and remained in the patient at the time of the lead extraction procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRANETICS LEAD LOCKING DEVICE
Type of Device
STYLET, CATHETER
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
9965 federal drive
colorado springs CO 80921
Manufacturer Contact
barbara creel
9965 federal drive
colorado springs, CO 80921
719447-246
MDR Report Key11055428
MDR Text Key229292930
Report Number1721279-2020-00262
Device Sequence Number1
Product Code DRB
Combination Product (y/n)Y
Reporter Country CodeBE
PMA/PMN Number
K142116
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberLLD EZ
Device Catalogue NumberUNAVAILABLE
Device Lot NumberUNAVAILABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-